Robert Andrews, CEO of the Health Transformation Alliance, addresses Medicaid rebates, cost-shifting concerns, and value-based pricing trends.
Robert Andrews
Advertisement
Robert Andrews is a former US Representative for New Jersey and is currently the chief executive officer of the Health Transformation Alliance.
Articles by Robert Andrews
Robert Andrews, CEO of the Health Transformation Alliance, discusses the implications of the new TrumpRx platform on drug pricing policy.
Advertisement
Latest Updated Articles
TrumpRx Effects on Medicaid Rebates, Cost-Shifting, and Value-Based Drug Pricing: Robert AndrewsPublished: October 9th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
3
Texas Sues J&J, Kenvue for Alleged Deception in Acetaminophen Marketing
4
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
5
